Skip to main content

Targeted newborn hearing screening in the neonatal intensive care unit of Assiut University Hospital

Research Authors
Kholoud Mohamed Omar1, Enass Sayed Mohamed1, Eman Abdel Fattah Said1, Nafisa H. R. AbdelAziz2 and Maha Abdelgaber A. Aly1*
Research Journal
The Egyptian Journal of Otolaryngology
Research Year
2022
Research Abstract

Background: Early detection of congenital hearing loss (HL) and appropriate intervention is essential to minimize
its dramatic impact. Target-based newborn hearing screening (TNHS) was initially targeted high-risk register (HRR)
newborn. The advance techniques in neonatology in neonatal intensive care unit (NICU) lead to decrease mortality
among low birth weight and preterm infants, but significant morbidities including hearing loss persist. In this study,
we aimed to assess the prevalence of hearing loss and the percentage of different risk factors among the HRR neonates
admitted to NICU at Assiut University Hospital.
Results: The prevalence of hearing loss among the study group is 1%. The most common risk factor present
between the study group was prematurity associated with the low birth weight (57%). The combination of preterm
and low birth weight has statistically significant effect on hearing loss (p < 0.006). There was statistically significant difference
in the pass rate of the transient evoked otoacoustic emission (TEOAE) frequencies included in the screening
program. The highest pass rate 91% and 85% was at 4 KH and 3 KH, respectively, while the least pass rate was at 1 KH
(11.5%).
Conclusion: TEOAE screener is safe, noninvasive, and doesn’t require sedation and cost-effective method in the newborn
hearing screening at NICU. For HRR, it is better to do screening before hospital discharge so allowing enough
time for comorbidities of the neonate to improve. Neonatal hearing screening in high-risk neonates in NICU allows
early identification of children with hearing loss with early intervention.